| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013562688 |
| P356 | DOI | 10.1007/S11060-008-9719-X |
| P932 | PMC publication ID | 3022444 |
| P698 | PubMed publication ID | 19009235 |
| P5875 | ResearchGate publication ID | 23473581 |
| P2093 | author name string | Sarah J Nelson | |
| Mitchel S Berger | |||
| Andrea Pirzkall | |||
| Susan M Chang | |||
| Kathleen R Lamborn | |||
| Soonmee Cha | |||
| Colleen McGue | |||
| Forrest W Crawford | |||
| Inas S Khayal | |||
| Suja Saraswathy | |||
| P2860 | cites work | Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors | Q30620964 |
| An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma | Q30627262 | ||
| Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging | Q30656712 | ||
| Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors | Q30657481 | ||
| Diffusion tensor MR imaging of high-grade cerebral gliomas | Q30687747 | ||
| Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging | Q30777038 | ||
| Imaging glioblastoma multiforme | Q30799855 | ||
| Treatment of malignant glioma: a problem beyond the margins of resection | Q31907699 | ||
| In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors | Q32034068 | ||
| A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival | Q34108339 | ||
| Diffusion and perfusion magnetic resonance imaging in brain tumors | Q34358902 | ||
| Adults with newly diagnosed high-grade gliomas | Q34677932 | ||
| Is the long‐term survival of patients with intracranial glioblastoma multiforme overstated? | Q35554569 | ||
| Comparison of single-shot localization methods (STEAM and PRESS) for in vivo proton NMR spectroscopy | Q35792156 | ||
| Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis | Q35800783 | ||
| MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences | Q36742386 | ||
| Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials | Q36771292 | ||
| Perfusion imaging with NMR contrast agents | Q38085998 | ||
| Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm | Q39512850 | ||
| Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas | Q40525983 | ||
| Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer | Q41715418 | ||
| Long-term survival in patients with supratentorial glioblastoma. | Q41731379 | ||
| Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence | Q42686851 | ||
| MR-spectroscopy guided target delineation for high-grade gliomas | Q43655485 | ||
| 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas | Q43960818 | ||
| Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas | Q43995293 | ||
| Registration of images from sequential MR studies of the brain | Q44634964 | ||
| Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging | Q44660901 | ||
| Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy | Q44742482 | ||
| 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. | Q44849163 | ||
| Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume | Q44866834 | ||
| Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. | Q45997469 | ||
| Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. | Q46024068 | ||
| Partially parallel MR spectroscopic imaging of gliomas at 3T. | Q46302315 | ||
| Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging | Q46463935 | ||
| Radiation response and survival time in patients with glioblastoma multiforme | Q46481977 | ||
| Feasibility of dynamic susceptibility contrast perfusion MR imaging at 3T using a standard quadrature head coil and eight-channel phased-array coil with and without SENSE reconstruction | Q46990726 | ||
| Apparent diffusion coefficient (ADC) measurements may be more reliable and reproducible than lesion volume on diffusion-weighted images from patients with acute ischaemic stroke-implications for study design | Q48228234 | ||
| Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas | Q48276582 | ||
| Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T. | Q48348165 | ||
| Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. | Q48503860 | ||
| Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. | Q48598106 | ||
| Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. | Q48784804 | ||
| The role of diffusion-weighted imaging in patients with brain tumors. | Q48836254 | ||
| The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme. | Q49145936 | ||
| [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma]. | Q55471234 | ||
| The role of tumor resection in the treatment of glioblastoma multiforme in adults. | Q55476478 | ||
| The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. | Q55476501 | ||
| Measuring blood volume and vascular transfer constant from dynamic,T2*-weighted contrast-enhanced MRI | Q57530352 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 337-351 | |
| P577 | publication date | 2008-11-15 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. | |
| P478 | volume | 91 |
| Q42594149 | (1)H spectroscopic imaging of human brain at 3 Tesla: comparison of fast three-dimensional magnetic resonance spectroscopic imaging techniques |
| Q26826862 | Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma |
| Q33888366 | Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI. |
| Q39439133 | Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen |
| Q48525569 | Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques. |
| Q42325580 | Automated prescription of oblique brain 3D magnetic resonance spectroscopic imaging |
| Q36088683 | Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting |
| Q39817583 | Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas |
| Q34935862 | Chemoirradiation for glioblastoma multiforme: the national cancer institute experience |
| Q39685607 | Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma |
| Q30764446 | Clinical proton MR spectroscopy in central nervous system disorders |
| Q37014722 | Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM |
| Q38810064 | Current and future strategies for treatment of glioma |
| Q64117470 | Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging |
| Q35815291 | Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial |
| Q40279363 | Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme |
| Q34498046 | Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy |
| Q48318624 | Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma |
| Q34992526 | Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM |
| Q48549430 | Fractional Anisotropy Correlates with Overall Survival in Glioblastoma. |
| Q48787869 | Histogram analysis of apparent diffusion coefficient within enhancing and nonenhancing tumor volumes in recurrent glioblastoma patients treated with bevacizumab. |
| Q40116790 | Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. |
| Q33657683 | Imaging of brain tumors: MR spectroscopy and metabolic imaging |
| Q36618214 | Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. |
| Q34440284 | Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients |
| Q41935740 | Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer-volume suppression saturation bands |
| Q36555913 | Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost |
| Q39476804 | Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma |
| Q31113520 | Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma |
| Q45892703 | Intraoperative visualization of residual tumor: the role of perfusion-weighted imaging in a high-field intraoperative magnetic resonance scanner |
| Q48757090 | Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma. |
| Q31015256 | Magnetic Resonance (MR) Metabolic Imaging in Glioma. |
| Q90972144 | Management of Glioblastoma, Present and Future |
| Q27002344 | Modern brain tumor imaging |
| Q39647863 | Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas |
| Q31115540 | Non-invasive metabolic imaging of brain tumours in the era of precision medicine |
| Q28544667 | Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histology |
| Q31103164 | Proton MRS imaging in pediatric brain tumors |
| Q36462756 | Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer? |
| Q44362904 | Recurrent high-grade glioma treated with bevacizumab: prognostic value of MGMT methylation, EGFR status and pretreatment MRI in determining response and survival |
| Q36048224 | Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging |
| Q38747896 | Restriction Spectrum Imaging Improves Risk Stratification in Patients with Glioblastoma. |
| Q37067588 | SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows |
| Q36889298 | Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery |
| Q37348479 | Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab |
| Q34977347 | Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. |
| Q35762234 | Spatial characteristics of newly diagnosed grade 3 glioma assessed by magnetic resonance metabolic and diffusion tensor imaging |
| Q36792743 | Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging |
| Q91940295 | Survival prediction of high-grade glioma patients with diffusion kurtosis imaging |
| Q35689991 | Volumetric and MGMT parameters in glioblastoma patients: survival analysis |
| Q38654095 | Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival |
| Q52151865 | Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination. |
Search more.